BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
1-Year Return
36.91%
This Quarter Return
+20.4%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$1.42B
AUM Growth
+$226M
(+19%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.93% |
| 2 | Consumer Staples | 35.39% |
| 3 | Industrials | 12.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.37B
| $562M | 39.52% |
8,783,082
| – | – |
|
2
Monster Beverage
MNST
$63.2B
| $503M | 35.39% |
9,312,976
| – | – |
|
3
Axon Enterprise
AXON
$59.4B
| $171M | 12.02% |
760,062
| – | – |
|
4
iShares Russell 2000 ETF
IWM
$66.9B
| $123M | 8.66% |
690,000
| – | – |
|
5
Lineage Cell Therapeutics
LCTX
$306M
| $52.4M | 3.69% |
34,935,485
| – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$88.1M
| $8.28M | 0.58% |
1,167,685
| – | – |
|
7
Serina Therapeutics
SER
$53.2M
| $1.99M | 0.14% |
85,219
| – | – |
|